ArticleJournal of medicinal chemistry2026
Predicting Ligand Binding Modes by Scaffold-Guided Structure Refinement.
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Efficient structure-based drug design relies on knowledge of a ligand's binding pose and its specific interactions─information that is often not available experimentally. Despite the plethora of binding mode prediction methods─including cofolding─achieved accuracies are often insufficient. Here, we present "Scaffold-Guided Structure Refinement", leveraging information on known binders within ligand series targeting a specific protein. Our method is based on the observation that shared molecular scaffolds among binders exhibit conserved binding modes. By applying molecular docking to diverse target model conformations, we identify those simultaneously allowing consistent scaffold placement, favorable interactions and low ligand strain. We demonstrate this approach's ability to optimize models from different initial sources─including an inaccurate cofolding model─in three case studies. In all cases, we successfully identified critical induced fit effects and accurately reconstructed near-native ligand binding modes with scaffold root-mean-square deviation (RMSD) values of at most 2.2 Å.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.